Table 1.
Patient baseline characteristics (n = 36).
| Patient characteristics | |
|---|---|
| Median age, years (range) | 67 (54–81) |
| Race (%) | |
| Caucasian | 91.6 |
| African American | 5.6 |
| Other | 2.8 |
| ECOG performance status 0 or 1 (%) | 100 |
| Median weight in kilograms (range) | 89.9 (70.2–177.9) |
| Median Gleason score | 8 |
| Median Primary Gleason grade | 4 |
| Disease location (%) | |
| Bone | 58.3 |
| Lymph node | 58.3 |
| Both | 22.2 |
| Analgesic use (%) | 36 |
| Previous cancer therapy (%) | |
| Androgen deprivation therapy | 100 |
| Antiandrogen | 94.4 |
| Second line anti-hormonal agent | 55.6 |
| Radical prostatectomy | 74.3 |
| Radiation to prostate or prostate bed | 58.3 |
| Chemotherapy | 30.6 |
| Docetaxel | 16.7 |
| Median laboratory values | |
| PSA (ng/mL) | 6.4 |
| Alkaline phosphatase+ (units/L) | 69 |
| Lactate dehydrogenase (units/L) | 452.5 |
| White blood cell count (cells/mm3) | 6.8 |
| Absolute neutrophil count (cells/mm3) | 3.8 |
+ The normal range for alkaline phosphatase is 31 to 131 units per liter, depending on age.